Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An extension trial to NN1250-3582 comparing safety and efficacy of NN1250 and insulin glargine, both with insulin aspart as meal-time insulin ± OADs in type 2 diabetes A 26 week controlled, open label, multicentre, multinational, treat-to-target extension trial comparing safety and efficacy of SIBA and insulin glargine both administered once daily in a basal-bolus regimen with insulin aspart as mealtime insulin ± treatment with metformin, ± pioglitazone in subjects with type 2 diabetes after a preceding 52 week treatment period with SIBA or insulin glargine both with mealtime insulin aspart ± treatment with metformin, ± pioglitazone in trial NN1250-3582 https://kusajili.fr:443/Trial/Qh1SZPxqbUqymTKvM1Ozfw%24an-extension-trial-to-nn1250-3582-comparing-safety-and-efficacy-of-nn1250-and-insulin-glargine-both-with-insulin-aspart-as-meal
I have read and accept the terms of use of the site and the Privacy Policy
Send your message